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Abstract
Background The Paleolithic diet is promoted worldwide for improved gut health. However, there is little evidence available
to support these claims, with existing literature examining anthropometric and cardiometabolic outcomes.
Objective To determine the association between dietary intake, markers of colonic health, microbiota, and serum trimethylamine-N-oxide (TMAO), a gut-derived metabolite associated with cardiovascular disease.
Design In a cross-sectional design, long-term (n = 44, > 1 year) self-reported followers of a Paleolithic diet (PD) and controls
(n = 47) consuming a diet typical of national recommendations were recruited. Diets were assessed via 3-day weighed diet
records; 48-h stool for short chain fatty acids using GC/MS, microbial composition via 16S rRNA sequencing of the V4
region using Illumina MiSeq. TMAO was quantified using LC–MS/MS.
Results Participants were grouped according to PD adherence; namely excluding grains and dairy products. Strict Paleolithic
(SP) (n = 22) and Pseudo-Paleolithic (PP) (n = 22) groups were formed. General linear modelling with age, gender, energy
intake and body fat percentage as covariates assessed differences between groups. Intake of resistant starch was lower in
both Paleolithic groups, compared to controls [2.62, 1.26 vs 4.48 g/day (P < 0.05)]; PERMANOVA analysis showed differences in microbiota composition (P < 0.05), with higher abundance of TMA-producer Hungatella in both Paleolithic groups
(P < 0.001). TMAO was higher in SP compared to PP and control (P < 0.01), and inversely associated with whole grain
intake (r = − 0.34, P < 0.01).
Conclusions Although the PD is promoted for improved gut health, results indicate long-term adherence is associated with
different gut microbiota and increased TMAO. A variety of fiber components, including whole grain sources may be required
to maintain gut and cardiovascular health.
Clinical trial registrations Australian and New Zealand Clinical Trial Registry (ANZCTRN12616001703493).
Keywords Paleolithic diet · Gut health · Resistant starch · TMAO · Whole grains
Abbreviations
TMAO	Trimethylamine-N-oxide
SP	Strict Paleolithic group
PP	Psuedo-Paleolithic group
PD	Paleolithic diet
RS	Resistant starch
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Introduction
The Paleolithic diet is a dietary pattern based on the hypothesis that the human genome has not adapted to consume
products of agriculture, and thus is based on consumption
of meat, fish, eggs, nuts, fruits and vegetables; with no processed foods, grains or dairy products included [1]. The diet
is promoted worldwide for improved gut health [2]. However, it excludes grains and dairy, food groups that form part
of the evidence-based national Australian and international
dietary guidelines [3, 4].
While total dietary fiber intake can be maintained on a
Paleolithic diet through fruit and vegetable consumption [5],
the exclusion of whole grains and legume products alters the
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fiber profile consumed, and in particular, results in reductions of resistant starch (RS) intake [6]. RS consistently
improves markers of bowel health, such as increased SCFA
levels [7–12], and long-term the effect of reduced intake has
not been previously explored, nor the implications for microbial diversity, metabolites, and other markers of gastrointestinal health. While the Paleolithic diet can be classed as a
low carbohydrate diet [5], other studies of low carbohydrate
diets and the impact on markers for gastrointestinal health
have been very low in total dietary fiber [13–16], thus limiting comparability to the current Paleolithic dietary patterns
and the impact on markers of gut health.
The elimination of grains, dairy and legume protein
sources, means PDs are rich in animal-based protein, which
may increase serum trimethylamine-N-oxide (TMAO) concentrations [17]. TMAO has been associated with CVD
and atherosclerotic plaque in both animal and human models [18–21], however, there is little evidence around how
TMAO concentrations vary with total dietary patterns in
healthy individuals. Given the established mechanism for
the production of TMA within the colon [18], modulations
of the gut microbiome through dietary intervention and
changes in fiber intake have the potential to alter circulating
TMAO concentrations. We have previously shown that a
short-term, 4-week intervention using the PD, did not significantly impact TMAO, but lowered RS intake, in a small
cohort of healthy Australian women [6]. However, longerterm studies of a PD have not examined the relationship
between RS intake and TMAO concentrations [22–24]. Our
short-term, randomised, controlled intervention study, comprised a small sample size and the energy restricted diet may
have limited our ability to detect significant differences in
TMAO concentrations [6]; furthermore, we did not concurrently examine fecal microbiota. Given the identified link
between TMAO concentrations and CVD [18–21], and the
limited literature regarding long-term health implications of
the PD, it is important to determine if the Paleolithic dietary
pattern alters the ability of the gut microbiota to produce
TMA. Therefore, the current cross sectional study compared
subjects with long-term (> 1 year) adherence to a Paleolithic
diet to those following a standard Australian diet to examine
the impact of each diet on gastrointestinal health and potential downstream effects on cardiovascular health.

Methods
Trial design
The study was designed as a cross-sectional comparator
study, and registered on the Australian and New Zealand
Clinical Trial Register (ANZCTRN12616001703493) and
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approved by the Edith Cowan University, Human Research
Ethics Committee (13402).

Participants
Recruitment for the study took place between August
2016 and June 2017 through online advertisements. Primary inclusion criteria for the Paleolithic diet group were
adherence to the dietary pattern for > 1 year period and
consumption of no more than 1 serve/day of grains and
dairy products. For inclusion in the control group, participants needed to have made no changes to their diet
in the previous year, and follow a relatively healthy diet
which included grains, legumes and dairy or alternatives.
Specific inclusion criteria for both groups were: men and
women aged 18–70 years; willingness to complete a 3-day
weighed diet records (3d WDR), provide blood, urine and
stool samples; non-smoker, not participating in other studies and had BMI < 30 kg/m2. Subjects were excluded if
they had taken antibiotics in the previous 6-month, had a
past or present digestive disorder, surgery on the gastrointestinal tract, used anti-hypertensive or lipid or glucoselowering medication, previous cardiovascular events or
diagnosed CVD. Participants were screened via email or
phone confirming exclusion/inclusion criteria were met
and provided written informed consent prior to study commencement. Participants completed a diet history interview, followed by a 3d WDR, including 2 week days and
1 weekend day. Samples collected were a 24-h urine and
fasted (overnight) blood sample. Portable freezers (WaecoCF-40,Dometic, Australia) were supplied to collect all
stool samples over a 48-h period. Physical activity was
assessed by the International Physical Activity Questionnaire [25].

Validity of dietary intake data
Dietary data provided by the 3d WDR were validated by
urine nitrogen analysed using a 1 in 50 dilution of urine
sample on a Shimadzu Total Carbon and Nitrogen Analyser,
TOC-Vcsh/TMN-1 (Shimadzu, Japan). Total nitrogen intake
was determined by dividing protein intake by 6.25 [26], with
an acceptable intake to excretion ratio set at 80% ± 24% [27].
Those with an intake to excretion ratio outside of this range
were deemed to be protein intake under or over reporters.
Potential energy under reporters were identified utilising the
Goldberg cut point [28]. Those who were identified as under
reporting both protein and energy were defined as unreliable
dietary reporters. Confirmation that the 3d WDR was representative of usual dietary intake was achieved by statistical
analysis of the energy and protein intake of both methods.
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Paleolithic scoring protocol
Due to individual differences in interpretation of the Paleolithic dietary pattern noted during data-entry of the 3d WDR,
a post hoc scoring protocol was developed to rank adherence
to the Paleolithic diet principles, namely the exclusion of
grain and dairy products. Those who consumed < 1 serve
per day of grains and dairy, in-line with the inclusion criteria, were allocated to the Strict Paleolithic (SP), while those
who consumed > 1 serve per day of grains and/or dairy were
allocated to the Pseudo-Paleolithic group (PP).

Outcomes assessment
Dietary intake
The diet history and 3d WDR data were entered into FoodWorks v8.0 [29], by the same assessor, a registered nutritionist with advanced competencies in dietary analysis. All
food records were checked for completeness. Minimum and
maximum RS content of each food item, utilised in the 91
food items generated from the 3d WDR, were determined
using methods described elsewhere [6].

Anthropometric measures
Subjects were fasted for 2-h prior to the clinic appointment
and reported dressed in tightly fitting gym clothes. Blood
pressure measurement was conducted, in duplicate, on the
right arm with an Omron IA1B Automated Blood Pressure
Device (Omron Health Care Ltd, Japan) at heart level, 1 min
apart. The mean of the two systolic and diastolic measures
respectively were recorded as per the protocol described by
the American Heart Foundation [30]. Standing height to the
nearest 0.1 cm was recorded using a SECA 763 digital stadiometer (SECA Ltd, USA). Waist circumference was measured to the nearest 0.1 cm at the narrowest part of the waist
by a Lufkin steel tape measure, following standardised ISAK
techniques [31]. The BodPod body composition chamber
(Cosmed, USA) calculated both weight and body fat percentage (to the nearest 0.001 kg and 0.01%, respectively).
As per the manufacturer’s protocol, hair was covered with a
tightly fitted cap, with all jewellery and footwear removed.

Stool form and biochemistry
Upon arrival at the university, the Bristol stool number
(as reported by the participant at collection time [32]) was
recorded. Each individual sample was weighed and the total
number of samples provided over the 48-h period allowed
the calculation of stool frequency (bowel motions/day).
Individual stool samples were stored at − 80 °C until sample processing, where they were defrosted at 4 °C overnight.
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Samples from the same participant were combined and
homogenised manually on ice for at least 1 min prior to
weighing and aliquoting for each individual assay. SCFA
analysis was undertaken using 1–1.5 g aliquots of stool using
methods described by Bajka et al. [33], with the addition of
a freeze–thaw distillation prior to GC analysis.
Moisture content was calculated by freeze-drying, in
duplicate, 40 g of pre-aliquoted stool sample for 7 days
using a Christ LD-alpha freeze drier (Martin Christ Ltd.,
Germany). Moisture content, expressed as a percentage, was
calculated from the mean of the two individual moisture
measurements.

Blood biochemistry
Participants reported to pathology for a blood test on the
morning after completion of the 3WDR, after an overnight
fast. Lipids were determined using standard enzymatic
techniques (Abbott Architect c16000 assay) by Pathwest,
a National Association of Testing Laboratories (NATA)
accredited laboratory. Serum samples, stored at − 80 °C,
were analysed for TMAO at the School of Science Analytical facility, Edith Cowan University, using the method
described by Le et al. [34].

Microbiota analysis
The microbial analysis were conducted at the WA Human
Microbiome Collaboration Centre, Curtin University, utilising the QIAmp PowerFecal DNA Kit for DNA extraction
and Illumina MiSeq platform for sequencing. Full methods
are available in the supplementary information.

Statistical methods
A priori power calculations were determined using G-Power
software [35] and were based on reductions to our primary
outcome variable, fecal butyrate excretion. Available literature suggested a medium to large Cohen’s effect size
(d = 0.595) could be expected [13], providing sample size
requirement of n = 72 at 80% power and α = 0.05, however,
given fiber intake can be maintained on a Paleolithic diet, a
more conservative estimate was determined using a medium
effect size (d = 0.5). The actual sample requirement was
therefore deemed to be between a total of n = 72 and n = 102,
with n = 36 and n = 51 per group, respectively.
Data were analysed using SPSS v24.0 [36]. Non-normally
distributed data were log10 transformed prior to analysis and
back-transformed to allow calculation of the estimated marginal means and corresponding 95% confidence intervals.
General linear modelling was used to compare the stratified Paleolithic vs control groups. Post hoc Bonferroni corrections were applied to P values from the three groups
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analysis. Amongst the entire cohort, exploration of associations between dietary intake, blood and stool biochemistry
were conducted using linear regression. All models included
age, gender, energy intake and body fat percentage as covariates, with additional covariates used where appropriate. Significance for the study was set at P < 0.05.
Microbiota analysis was conducted using Primer 7 (Quest
Research, NZ) with permutation multivariate analysis of
variance (PERMANOVA) [37]. At the phylum and genus
level, relative abundance data were square or fourth root
transformed, prior to the calculation of a Bray–Curtis similarity matrix. Principal coordinates analysis (PCO) was used
to examine possible differences or separations among the
groups visually at the 2-D level. This was followed by PERMANOVA to formally assess differences between groups.
Dissimilarity percentage (SIMPER) analysis was used to
determine the contribution of individual phyla and genera
driving the average dissimilarities between groups based
on the Bray–Curtis similarity matrix. Distance-based linear
modelling (DistLM) was utilised to describe the patterns in
the microbiota using the dietary intake variables. Measures
of diversity were calculated using the Shannon and Simpson
indices. The Bacteriodetes:Firmicutes ratio was calculated
and exported to SPSS v24.0 (IBM Corporation, USA) [36]
for analysis.
All analyses were conducted with and without the inclusion of participants identified as unreliable dietary reporters.
Where the inclusion of these participants did not influence
statistical significance of our findings, the reported results
include all participants.

Results
Participants
As shown in Fig. 1, 90 subjects completed the study with
partial data available for an additional control subject. Participant characteristics are presented in Table 1. No significant differences were found between groups for age, height,
energy intake or physical activity. The average length of
time Paleolithic participants had followed the diet was
2.38 ± 1.08 years. In terms of being representative of longterm dietary intake, bivariate correlations of energy and protein with the diet history showed good agreement (R = 0.596
and 0.763 respectively, P < 0.01) and a one sample t test
showed the energy and protein intake determined from the
3d WDR and the diet history were not significantly different
(P = 0.623 and 0.059 respectively). A Bland–Altman plot
[38] confirmed acceptable agreement between urinary nitrogen and calculated nitrogen intake from protein intake (data
not shown); and a one-sample t test showed no difference
between these variables (P = 0.337). Five participants were
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identified as under-reporting both energy and protein intake,
two from the SP group and three from the control group. The
scoring protocol was used to rank participants according to
adherence to the diet (Table 1). Body weight was significantly greater in the Pseudo-Paleolithic (PP) group, when
compared to the controls, but there were no other differences
between groups identified.

Dietary intake
Total dietary fiber (TDF) intake in the SP group was not
different from that of the control (Table 2), however the PP
group had fiber intake below the recommended Australian
adequate intake (AI) of 25 g/day. In line with the significantly lower TDF intake in the PP group, both soluble and
insoluble fibre intake was also lower, when compared to the
control group. RS intake was significantly lower in the SP
and PP groups at both minimum and maximum estimated
intakes (Table 2). Despite the low carbohydrate intake,
vegetable intake in the SP group met the Australian recommendations of 5 serves per day [3], with a mean intake
significantly higher than that of the control group. Across the
whole cohort, total fiber intake was inversely associated with
body weight [t(86) = − 4.22, partial r = − 0.414, P < 0.001),
body fat percentage [t(86) = − 2.282, partial r = − 0.239,
P = 0.025] and waist circumference [t(85) = − 3.397, partial r = − 0.346, P = 0.001]. Protein intake as percentage of
energy and absolute intake in grams per day, was significantly higher in the SP group, when compared to the control and PP (Table 2). Fat intake was significantly higher
in both Paleolithic groups, when compared to the control
(Table 2). Saturated fat intake in all dietary groups exceeded
the recommended intake of 10% of energy [3], with intakes
in both of the Paleolithic groups more than double the recommended Australian and international levels [3, 39].

Blood biochemistry
Total serum cholesterol was higher in the PP, when compared to the control group (Table 3). High-density lipoprotein (HDL) cholesterol was significantly higher in the SP
and PP groups, when compared to the control group and led
to non-significant differences among the groups in the total
cholesterol:HDL cholesterol ratio (Table 3). Total serum
cholesterol concentrations were inversely associated with
carbohydrate intake, both expressed as g/day [t(77) = − 2.47,
partial r = − 0.271, P = 0.016] and as a percentage of energy
[t(77) = − 2.54, partial r = − 0.280, P = 0.013]. Further exploration showed significant negative association with the minimum [t(77) = − 3.329, partial r = − 0.355, P = 0.001], and
maximum RS intakes [t(77) = − 2.922, partial r = − 0.316,
P = 0.005] and whole grain intake [t(77) = − 2.032,
r = − 0.226, P = 0.046].
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Fig. 1  Flow diagram of the study. Of the 231 enquiries received, 92 participants were accepted into the study. Two participants in the control
group withdrew due to illness, with partial data available for one subject. 44 Paleolithic and 46 controls completed the study data collection

TMAO was significantly higher in the SP group,
when compared to the control group (Table 3). TMAO
concentrations were associated with servings of red
meat [t(67) = 3.372, partial r = 0.357, P = 0.001], and
inversely associated with total grain [t(83) = − 3.143,
partial r = − 0.335, P = 0.002] and whole grain intake
[t(83) = − 2.973, partial r = − 0.319, P = 0.004], respectively.

Stool biochemistry
There was no difference in daily stool weight or form but
stool frequency was greater in the PP group when compared to the control group (Table 3). Regression analysis
across the whole cohort showed stool frequency was significantly associated with nut and seed consumption after
adjustment for energy intake [t(87) = 2.14, partial r = 0.223,
P = 0.036], with each serve of nuts increasing motions/day

by 0.12. There were no significant differences in SCFA
excretion between groups, however, total SCFA excretion was associated with fiber intake [t(84) = 2.331, partial
r = 0.247, P = 0.022], but not with carbohydrate (expressed
as a percentage of energy and g/day), grains, whole grains,
or RS intake. Total dietary fibre predicted butyrate excretion [t(84) = 2.232, partial r = 0.237, P = 0.028] but no relationships with wholegrains, grains and resistant starch were
noted. Vegetable intake significantly predicted total SCFA
excretion [t(84) = 2.27, partial r = 0.240, P = 0.026] and further analysis showed the association was due intakes of the
dark green vegetable group [t(84) = 2.047, partial r = 0.218,
P = 0.044], with similar associations seen for acetate excretion; vegetables were associated with acetate excretion
[t(84) = 2.69, partial r = 0.281, P = 0.009], and subgroup
analysis showed the association was due to the dark green
vegetables [t(5,84) = 2.52, partial r = 0.265, P = 0.014].
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Table 1  Participant
characteristics by dietary group
N
Age (years)a
Height (cm)
Weight (kg)
BMI (kg/m2)
Systolic blood pressure (mmHg)
Diastolic blood pressure (mmHg)
Waist circumference (cm)
Body fat (%)
Energy intake (kJ)
Physical activity (PAL)b

Control
Mean (95% CI)

Strict Paleolithic (SP)
Mean (95% CI)

Pseudo-Paleolithic (PP)
Mean (95% CI)

47
38.96 (35.02, 42.90)
169.6 (167.9, 171.4)
69.19 (65.58, 72.79)
23.94 (22.78, 25.10)
120 (114, 125)
79 (75, 83)
81.3 (78.1, 84.5)
22.68 (20.21, 25.14)
9384 (8800, 9968)
1.82 (1.79, 1.86)

22
41.49 (35.46, 47.53)
169.8 (167.1, 172.5)
70.23 (64.74, 75.72)
24.33 (22.56, 26.10)
116 (109, 124)
75 (70, 81)
83.0 (78.2, 87.8)
22.38 (18.63, 26.13)
9171 (8282, 10059)
1.87 (1.81, 1.93)

22
45.33 (39.69, 50.96)
172.8 (170.3, 175.3)
79.08 (73.89, 84.27)**
26.39 (24.72, 28.07)
114 (107, 125)
77 (72, 82)
86.1 (81.7, 90.6)
25.96 (22.41, 29.50)
9812 (8972, 10652)
1.83 (1.77, 1.86)

**P < 0.01 different from control group. Means calculated using general linear modelling with the addition
of age and gender as covariates

a

b

Unadjusted mean

PAL Score derived from PAL ranking (from IPAQ Scoring Protocol) [40] and converted to PAL score
[41]

Microbiota profiles
The sequence data yielded 929 denoised operational taxonomic units (OTU) with an average 38,899 reads per sample
(ranging from 2647 to 107,597 reads). Two participants from
the control group were inadvertently tagged with identical
forward and reverse barcodes and were excluded from the
analysis. OTU comprising less than 0.01% of the total reads
were eliminated (514 OTU), leaving 415 available for analysis. Five sequence controls comprised total reads between
3409 and 11,560. Five OTU not related to the gut microbiota, were present primarily in the blank samples, totalling
11,210 reads and were removed from the analysis. One OTU
(432 reads) comprised human mitochondrial DNA and were
also excluded from the analysis. The final dataset included
410 total OTU’s, which was converted to relative abundance
before importing to PRIMER 7 [37] for analysis.
The microbial composition was analysed both at the
phylum and at the genus level to examine major and more
specific shifts in the gut microbiota between the three
dietary groups. At the phylum level, there was no difference between groups for measures of diversity (Shannon
and Simpson indices) or species richness between the three
groups (Table S1). However, PERMANOVA analysis at the
phylum level showed significant differences in microbiota
composition between the control and PP groups (P = 0.048)
and the SP and PP groups (P = 0.001). No difference was
observed between the SP and control groups. SIMPER
analysis indicated that group differences were driven by the
relative abundances of Bacteriodetes, Firmicutes and Verrucomicrobia phyla. The relationship between Bacteriodetes
and Firmicutes has been linked with increased body fat [40,
41], therefore, the overall Bacteriodetes:Firmicutes ratio was
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calculated, and between-group differences were evaluated
using general linear modelling, with the addition of age,
gender, energy intake and body fat percentage as covariates in the model. No differences were observed between
the three groups. Although, in the entire cohort body fat
percentage (partial R = − 0.33, P = 0.032) and energy intake
(partial R = − 0.23, P = 0.033) were significant predictors of
the ratio in a linear regression model.
At the genus level, there were no significant differences
between the three groups, in measures of Shannon or Simpson diversities, and species richness. PERMANOVA analysis with covariates age, gender, energy intake and body
fat percentage, showed there were significant differences
between the SP and control (P = 0.004) and PP and control
(P = 0.04), with no significant difference between the two
Paleolithic groups.
DistLM showed a significant influence of vegetable intake
(P < 0.01), in addition to significant influences of whole
grains (P < 0.01), RS maximum estimation (P < 0.01), total
carbohydrate (P < 0.01) and total fat (P = 0.04) on the microbial composition (Fig. 2).
Having established significant differences at the genera
level, SIMPER analysis was used to determine the species
which contributed to the differences identified between
groups. The average dissimilarity between SP and control
groups was 27.25%, SP and PP 26.27% and PP and control
27.13%. Abundant genera driving dissimilarities between
groups were Bacteriodes, Faecalibacterium, Blatia, Ruminoclostridium, Alistipes, Roseburia, Ruminococcus, Lachnospiracea Incertae sedis, Ruminoclostridium, Anaerostipes,
Gemmiger, Irregularibacter, Akkermansia. After adjustment
for the study covariates, age, gender, energy intake and body
fat percentage, three of these genera were identified as being
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Table 2  Energy, macronutrient and food group intake by dietary group
Strict Paleolithic
Mean (95% CI)b
(n = 22)

Effect size Pseudo-Paleolithic
Mean (95% CI)b
(SP vs
control)
(n = 22)

Effect size
(PP vs control)

Overall dietary
effect P valuec

Dietary variable

Control
Mean (95% CI)a,b
(n = 47)

Energy intake (kJ)
Protein (g)

9187 (8599, 9774)
8955 (8076, 9834)
− 0.13
92.16 (83.69, 100.63) 118.07 (105.69,
1.02
130.44)**
18.49 (16.87, 20.12)
23.63 (21.25, 26.00)** 1.02
202.62 (187.84, 217.41) 99.19 (77.60, 120.79)** − 2.33
38.03 (35.49, 40.57)
16.75 (13.03, 20.46)** − 2.79

0.33
0.39

0.285
0.001

20.13 (17.81, 22.45)
0.39
81.40 (60.34, 102.47)** − 2.59
16.41 (12.79, 20.03)** − 2.69

0.001
< 0.001
< 0.001

75.58 (66.05, 85.11)
51.77 (37.85, 65.68)** − 0.83
124.56 (112.87, 136.26) 45.86 (28.78, 62.95)** − 2.24
82.53 (76.33, 88.72) 117.91 (108.86,
1.90
126.96)**
36.45 (33.9, 39)
52.95 (49.22, 56.67)** 2.15
27.34 (22.77, 31.9)
45.51 (38.84, 52.18)** 1.33
12.02 (10.05, 13.99)
20.59 (17.71, 23.47)** 1.45

44.34 (30.76, 57.91)** − 1.04
34.74 (18.07, 51.4)** − 2.43
2.58
133.16 (124.34,
141.99)**
56.96 (53.33, 60.6)**
2.54
52.47 (45.97, 58.98)**
1.74
22.09 (19.28, 24.9)**
1.61

< 0.001
< 0.001
< 0.001

Protein (% of energy)
Carbohydrate (g)
Carbohydrate (% of
energy)
Sugars (g)
Starch (g)
Total fat (g)

Fat (% of energy)
Saturated fat (g)
Saturated fat (% of
energy)
Polyunsaturated fat (g) 15.17 (13.21, 17.14)
16.86 (13.98, 19.73)
0.29
Monounsaturated fat
32.96 (29.63, 36.28)
45.01 (40.16, 49.86)** 1.21
(g)
Cholesterol (mg)
324.19 (225.29, 423.08) 708.28 (563.84,
1.29
852.73)**
Total dietary fiber (g)
29.66 (26.36, 32.96)
27.41 (22.59, 32.23) − 0.23
Soluble dietary fiber
11.99 (10.45, 13.53)
10.78 (8.54, 13.03)
− 0.26
(g)
Insoluble dietary fiber
17.07 (15.11, 19.03)
16.17 (13.3, 19.04)
− 0.15
(g)
Resistant starch mini4.48 (3.89, 5.06)
2.62 (1.77, 3.47)** − 1.03
mum (g)
Resistant starch maxi14.16 (12.24, 16.07)
6.13 (3.34, 8.93)** − 1.35
mum (g)
Alcohol (g)
7.07 (3.73, 10.4)
8.31 (3.44, 13.19)
0.12
3.83 (2.99, 4.66)
6.68 (5.51, 7.84)**
1.12
Vegetables serves/
day (fresh equivalent
150–350 kJ)
0.39 (0.17, 0.61)
1.28 (0.97, 1.59)**
1.34
Dark green vegetable
serves/day (fresh
equivalent 100 kJ)
Nuts and seeds (30 g
0.82 (0.48, 1.15)
1.07 (0.59, 1.56)
0.26
protein equivalent)
0.44 (0.21, 0.66)
0.80 (0.47, 1.13)
0.52
Red meat serves/
day (20 g protein
equivalent)
Eggs serves/day (13 g
0.20 (0.09, 0.30)
1.05 (0.72, 1.38)**
0.87
protein equivalent)
6.14 (5.29, 7.04)
0.19 (0.03, 0.47)** − 3.80
Total grains serves/
day (14–16 g starch
equivalent)
2.91 (2.28, 3.61)
0.09 (0.00, 0.34)** − 2.32
Whole grain serves/
day (14 g starch
equivalent)
1.60 (1.25, 2.0)
0.17 (0.04, 0.37)*
− 1.26
Total dairy serves/day
(300 mg calcium
equivalent)

9820 (9005, 10635)
102.7 (90.62, 114.77)

17.47 (14.67, 20.28)
52.28 (47.55, 57.02)**

< 0.001
< 0.001
< 0.001

0.37
1.84

0.295
< 0.001

685.00 (544.10,
825.90)**
20.79 (16.09, 25.49)*
7.62 (5.43, 9.81)**

1.15

< 0.001

− 0.85
− 0.90

0.006
0.004

12.87 (10.07, 15.66)*

− 0.68

0.036

1.26 (0.43, 2.09)**

− 1.75

< 0.001

2.95 (0.22, 5.68)**

− 1.85

< 0.001

10.34 (5.59, 15.09)
4.31 (3.17, 5.44)

0.31
0.16

0.488
< 0.001

0.70 (0.41, 1.00)

0.45

< 0.001

1.32 (0.84, 1.79)

0.48

0.167

0.77 (0.45, 1.09)

0.46

0.066

0.89 (0.57, 1.21)*

0.63

< 0.001

0.63 (0.30, 1.08)**

− 3.07

< 0.001

0.16 (0.01, 0.46)**

− 2.09

< 0.001

0.87 (0.54, 1.27)*

− 0.73

< 0.001
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Table 2  (continued)
P values for stratified Paleolithic groups were adjusted using post hoc Bonferroni correction [43]
Significant P values are in bold
a

General linear modelling used to determine estimated marginal means and the difference between control and the overall Paleolithic groups
after adjustment for age, gender, energy intake and body fat percentage.**P ≤ 0.01 different from control group, *P ≤ 0.05 different to control
group

b
General linear modelling used to determine estimated marginal means and the difference between control, strict Paleolithic and Pseudo-Paleolithic groups after adjustment for age, gender, energy intake and body fat percentage.**P ≤ 0.01 different from control group, *P ≤ 0.05 different
to control group. P < 0.01 different from Strict Paleolithic group, P < 0.05 different from the SP group
c

Significance of the overall general linear model for the three group analysis. Effect sizes reported using Cohen’s d, with a value of 0.2 representing a small effect, 0.5 a medium effect and 0.8 a large effect

significantly different between groups, Bifidobacteria, Roseburia, and Hungatella (Fig. 3a–c).
Relative abundance of Hungatella was significantly and
inversely associated with grain consumption in a linear
regression model after adjustment for age, gender, body fat
and stool frequency (partial r = − 0.298, P = 0.006). Relative
abundance of Roseburia was significantly related to total
grain (partial r = 0.315, P = 0.002), whole grain (partial
r = 0.298, P = 0.004) and carbohydrate consumption (partial r = 0.297, P = 0.004), but not with dietary fiber, or RS
minimum or maximum estimates. Similar to Roseburia, Bifidobacteria abundance was related to total grain consumption
(partial r = 0.266, P = 0.008) and the percentage of energy
derived from carbohydrate (partial r = 0.221, P = 0.028),
but not with RSi, whole grains or total dietary fiber. In a
linear regression model, relative abundances of Roseburia
and Bifidobacteria were significantly and inversely correlated with the abundance of Hungatella [t(87) = − 2.1, partial
r = − 0.2, P = 0.03]. In line with the TMAO findings, relative
abundance of Hungatella was also significantly associated
with servings of protein foods per day [t(87) = − 2.84, partial
r = 0.27, P = 0.006].

Discussion
This study evaluated the gastrointestinal implications of low
carbohydrate, high fat, Paleolithic style diets through comparison with a cohort of healthy Australians in a cross-sectional study design. Consumption of a long-term Paleolithic
diet was associated with markedly higher serum TMAO concentrations, but only in those who adhered to the diet strictly.
Romano et al. [42], identified six species of bacteria associated with choline consumption and production of TMA,
of which, one was identified in our cohort, Clostridium
hathewayi, originating from the genera Hungatella. We did
not identify the other species reported by Romano et al. [42],
although our methods of short amplicon sequencing are not
typically used to identify individual species, but rather provide robust data at the genus level. It is therefore possible the
other species were present, but not identified at the species
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level in our cohort. Nonetheless, the relative abundance of
the Hungatella genus was significantly higher in both the SP
and PP groups. Our results show that serum TMAO concentrations and Hungatella abundance were inversely associated
with total and whole grain consumption, indicating these
food groups may downregulate the ability of Hungatella to
dominate or interfere with the production of TMA. Notably,
TMAO concentrations in the PP group were not statistically
different from the controls, despite the increased Hungatella
abundance and small to medium effect size noted. The stratification of the Paleolithic group into two groups may have
reduced our ability to detect significance of this outcome
variable. Furthermore, the lower overall fiber and higher fat
content of the PP diet may have influenced the fermentative
capacity of the microbiota to produce TMA, given high fat
diets may attenuate the fermentation response [43].
Bergeron et al. [44] detected changes in TMAO concentrations after a 2-week dietary intervention with 52 subjects
and found low carbohydrate diets, high in RS, were associated with increased plasma TMAO. Conversely, in the current study TMAO was not associated with RS, but inversely
associated with grain intake. This may indicate that other
components of the grain carbohydrate and fiber are responsible for modulating abundances of Hungatella. Bergeron
et al. [44] did not report food group intake for the intervention diets, which limits comparability with our study. In support of the findings presented here is the identification of the
genera associated with producing TMA in the fecal microbiota [42], in addition to the statistical association found
with red meat intake, a known TMA precursor food [45].
While there were no observed differences in measures of
fecal microbiota diversity (α-diversity), a significant group
difference (β-diversity) at both the phylum and genus levels
were reported. An inverse association was found between the
Bacteriodetes:Firmicutes ratio and body fat, supporting previous research showing a reduced ratio was associated with
obesity [40, 41, 46]. At the genus level, different community
structures were associated with intakes of vegetables, dietary
fat, RS, whole grain and dietary fiber. The direction of the
shift in microbiota composition was similar for vegetable
intake, whole grains, RS and dietary fiber and is likely to be
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Table 3  Biochemistry results by dietary group
Biomarker

Control
Mean (95% CI)a,b
(n = 46)

Strict Paleolithic
Mean (95% CI)b
(n = 22)

Effect size (strict
Paleolithic vs
control)

Blood biochemistry
Total Cholesterol
4.88 (4.51, 5.26)
5.02 (4.48, 5.56)
0.13
(mmol/L)
3.00 (2.70, 3.30)
3.10 (2.66, 3.53)
0.12
LDL Cholesterold
(mmol/L)
HDL Cholesterol
1.43 (1.29, 1.57)
1.69 (1.49, 1.89)** 0.64
(mmol/L)
Total Cholesterol/
3.49 (3.21, 3.77)
3.14 (2.73, 3.55) − 0.41
HDL Ratio
Triglycerides
0.94 (0.88, 1.0)
0.86 (0.79, 0.94) − 0.49
(mmol/L)
Serum TMAO
3.93 (2.79, 5.55) 9.53 (5.86, 15.49)** 0.86
(µM)e
Stool markers
Stool weight (g/day 194.57 (161.7,
248.81 (200.55,
0.55
wet weight)
227.43)
297.06)
Frequency (motions
1.37 (1.19, 1.54)
1.60 (1.35, 1.85)
0.46
per day)
Bristol number [31]
4.12 (3.75, 4.48)
4.3 (3.76, 4.84)
0.18
Moisture (%)
73.96 (72.04, 75.89) 74.69 (71.86, 77.52) 0.12
7.19 (7.05, 7.36)
7.19 (6.97, 7.41) − 0.33
pHe
1.09 (0.69, 1.5)
1.16 (0.57, 1.75)
0.07
Residual fecal fat
(%)e
Acetate excretion
7.80 (6.18, 9.86) 10.52 (7.46, 14.86) 0.41
(mmol/day)e
Propionate excre2.36 (1.87, 2.98)
2.76 (1.96, 3.89)
0.80
tion (mmol/day)e
Isobutyrate excre0.27 (0.23, 0.32)
0.34 (0.26, 0.44)
0.42
tion (mmol/day)e
Butyrate excretion
2.21 (1.72, 2.84)
2.86 (1.98, 4.13)
0.33
(mmol/day)e
Isovalerate excre0.39 (0.33, 0.46)
0.45 (0.36, 0.58)
0.29
tion (mmol/day)e
Valerate excretion
0.30 (0.25, 0.36)
0.37 (0.29, 0.49)
0.40
(mmol/day)e
Caproate excretion
0.05 (0.04, 0.08)
0.06 (0.03, 0.11)
0.05
(µmol/day)e
Total SCFA excre13.74 (11.02, 17.14) 17.91 (12.94, 24.83) 0.38
tion (mmol/day)e

Pseudo-Paleolithic
Mean (95% CI)b
(n = 22)

Overall dietary
Effect size
(Pseudo-Paleolithic effect P v aluec
vs control)

5.60 (5.10, 6.11)*

0.65

0.050

3.49 (3.09, 3.90)

0.55

0.113

1.79 (1.61, 1.98)*

0.88

0.003

3.25 (2.87, 3.64) − 0.28

0.122

0.84 (0.77, 0.91) − 0.60

0.049

5.47 (3.42, 8.75)

0.32

0.008

233.04 (186.03,
0.37
280.05)
1.91 (1.67, 2.16)** 1.03

0.099

4.54 (4.02, 5.07)
0.38
74.5 (71.74, 77.26) 0.09
7.18 (6.97, 7.4) − 0.06
1.70 (1.13, 2.27)
0.49

0.338
0.880
0.974
0.165

0.001

9.06 (6.49, 12.68)

0.19

0.288

2.82 (2.02, 3.94)

0.70

0.546

0.34 (0.27, 0.44)

0.41

0.152

2.85 (1.99, 4.07)

0.32

0.315

0.48 (0.38, 0.61)

0.39

0.255

0.38 (0.29, 0.49)

0.41

0.136

0.08 (0.04, 0.15)

0.28

0.618

16.41 (11.94, 22.54) 0.25

0.299

Significant P values are in bold
a

General linear modelling used to determine estimated marginal means and the difference between control and the overall Paleolithic groups
after adjustment for age, gender, energy intake and body fat percentage.**P ≤ 0.01 different from control group, *P ≤ 0.05 different from control
group

b
General linear modelling used to determine estimated marginal means and the difference between control, strict Paleolithic and Pseudo Paleolithic groups after adjustment for age, gender, energy intake and body fat percentage.**P ≤ 0.01 different from control group, *P ≤ 0.05 different
from control group
c

Significance of the overall general linear model for the three group analysis. Effect sizes reported using Cohen’s d, with a value of 0.2 representing a small effect, 0.5 a medium effect and 0.8 a large effect

d
e

LDL Cholesterol reported is calculated LDL. P values for stratified Paleolithic groups adjusted using post hoc Bonferroni correction [43]
Log transformation conducted prior to analysis
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Fig. 2  Distance-based redundancy plot, showing the effect of dietary
intake, overlaid with serum TMAO, and microbiota composition. The
added dietary variable vectors show the correlation between the dietary factor and the microbiota composition. The length of the line is
indicative of the strength of the association. Whole grains (P < 0.01),
carbohydrate (P < 0.01) and RS (P < 0.01) are associated with a shift
in composition towards the top of the plot, consistent with microbi-

ota composition of the control group. However, dietary fat (P = 0.04)
was associated with a shift in the opposite direction, with vegetables
(P < 0.01) falling in between the two groups. Consistent with the
serum TMAO increase in the SP group, TMAO is closely aligned
with microbiota composition, total fat and red meat consumption (P
trend = 0.09)

beneficial, given the large body of evidence associated with
health benefits from consumption of these food groups [3,
47–54]. Conversely the direction of the shift in microbiota
composition associated with fat consumption was in the
opposite direction and suggests a more deleterious profile.
Reductions to core bacteria including Roseburia, as seen in
the current study, have been associated with inflammatory
bowel diseases [55]. In animal models, high-fat diets have
been shown to drive obesity independently of the composition
of the microbiota [56]. There were reductions in the Paleolithic dietary groups to genera Roseburia and Bifidobacterium,
known to metabolise carbohydrate and produce butyrate.
Moreover, low abundances of known beneficial genera such as
Bifidobacterium in the Paleolithic groups support the findings
of Brinkworth et al. [13], who reported low abundances of this
genera after an 8 week low-carbohydrate diet, comprising 58%
fat [13]. A decrease in relative abundance of Bifidobacterium
has been previously associated with irritable bowel syndrome,
and obesity [57], however, these disorders have also been
associated with lower fecal excretion of acetate and butyrate,
which was not found in the current cohort. Given that total fat
intake was associated with microbiota composition at both the
phylum and genus level, and positively correlated with body

weight, the differences observed in microbiota composition
are unlikely to be beneficial.
Supporting our previous findings from a short-term
intervention using the Paleolithic diet [6], the elimination
of the grains food group on a Paleolithic diet resulted in
a significantly lower intake of RS than the control group,
despite no significant differences found in total soluble or
insoluble fiber intakes. Intakes of RS in the control group
were slightly higher than previous estimates of Australian
intakes of 3.4–9.4 g/day [58] and may be due to higher consumption of whole grains than the average Australian intake
of 1.5 serves/day [59]. Both groups consumed less than the
proposed 20 g RS/day required for bowel health [60] and
may be an area for focus in future interventions.
Despite the differences in RS intake, we did not observe any
differences between groups in SCFA excretion. While this was
an unexpected finding, the high intake of saturated fat in the
Paleolithic groups may have influenced the results, given Fava
et al. [61], showed fecal SCFA concentrations were higher
following a 4-week diet comprising 17% saturated fat in 88
participants at risk of metabolic syndrome. It is not yet understood whether saturated fat leads to changes in fermentation
patterns or alterations to colonic uptake of SCFA. Differences
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Fig. 3  a–c Significant contributors to genera differences between groups. Bar graphs show relative abundances by dietary group. **P < 0.01 difference between control and PP/SP groups

in microbiota composition attributed to the intervention diets
used by Fava et al. [61] were assessed using fluorescence in situ
hybridisation (FISH), which limits comparability with the current study. In addition, the lack of difference we observed for
SCFA excretion may have been due to the differences in the
sites of fermentation for grains as opposed to vegetables, with
the latter likely to be fermented in the distal colon due to the
difference in fiber structure, although there is little literature
in this area. Even though fecal acetate concentration has been
inversely associated with acetate absorption [62] fecal SCFA
may not provide a sensitive enough marker to estimate differences in total fermentation along the colon. [63].
Previous short-term interventions using the Paleolithic diet
have found increases to HDL cholesterol in diabetics [64],
but not in healthy populations [5, 65–67], however, the latter
also reported reductions to total and LDL cholesterol, in addition to significant weight loss, which may have influenced
HDL concentrations. Further, a 2-year intervention showed
no significant change in total or HDL cholesterol, despite
significant reductions in triglycerides over the intervention
period [23]. The current data showed small, but significantly
greater HDL concentrations in the Paleolithic groups, which
were associated with the reduction in carbohydrate intake,
and increase in saturated fat consumption. The findings
reported here support previous work showing that saturated
fat consumption increases concentrations of calculated HDL

cholesterol [68]. The current study also shows a significant
relationship between saturated fat consumption and total
cholesterol levels. A systematic review and meta-analysis
showed that for every 1 mmol/L increase in total cholesterol,
the relative risk of CVD was 1.20 for women (95% CI 1.16,
1.24) and 1.24 in men (1.20, 1.28) [69]. Therefore, while
there may be conflicting evidence surrounding the specific
effect of saturated fat consumption on CVD risk, the positive
association noted in the current data between saturated fat
and HDL concentrations must be interpreted with caution, as
saturated fat intake was also associated with total cholesterol
concentrations in the Paleolithic groups and may result in
increased CVD risk over a longer-term period. Furthermore,
we found a positive association between saturated fat intake,
body weight, and BMI, which are known to increase CVD
risk [70]. Taken together with the greater observed serum
TMAO concentrations, it cannot be concluded that the Paleolithic diet is associated with improved gut health and a reduction in risk of CVD as promoted [71, 72].

Conclusion
The cross-sectional data collected suggests that long-term
adherence to the Paleolithic diet may not be beneficial for gut
health, due to the association with lower relative abundances
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of known beneficial bacterial genera, and the increased relative abundance of TMA producing genera Hungatella. Our
findings highlight that further research is required to understand the role of vegetables and saturated fat and how they
influence colonic uptake of SCFA and subsequent excretion.
The rationale to exclude whole grains is not supported by
data presented here; being inversely associated with body
weight and TMAO concentrations. Despite the maintenance
of SCFA excretion, and stool frequency and form, the differences noted in microbiota composition associated with the
high fat and low carbohydrate intake may not be beneficial
for long-term health.
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